Taken together, we have here demonstrated that silencing of SND1 increases the level of several tumor suppressor miRNAs and sensitizes cancer cells especially to MEK-ERK pathway inhibitors and Bcl-2/Bcl-XL inhibitor navitoclax. The gene discussed is MAP2K7; the disease is neoplasm.